UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Amphiphilic Dendrimer Doping Enhanced pH-Sensitivity of Liposomal Vesicle for Effective Co-delivery toward Synergistic Ferroptosis–Apoptosis Therapy of Hepatocellular Carcinoma Journal article
Yanhong Su, Zhao Zhang, Leo Tsz On Lee, Ling Peng, Ligong Lu, Xu He, Xuanjun Zhang. Amphiphilic Dendrimer Doping Enhanced pH-Sensitivity of Liposomal Vesicle for Effective Co-delivery toward Synergistic Ferroptosis–Apoptosis Therapy of Hepatocellular Carcinoma[J]. Advanced Healthcare Materials, 2023, 12(6).
Authors:  Yanhong Su;  Zhao Zhang;  Leo Tsz On Lee;  Ling Peng;  Ligong Lu; et al.
Favorite | TC[WOS]:25 TC[Scopus]:25  IF:10.0/11.3 | Submit date:2023/08/03
Advanced Hepatocellular Carcinoma  Amphiphilic Dendrimers  Ferroptosis  Liposomal Vesicles  Synergistic Therapy  
Clinical Outcomes Associated with Monotherapy and Combination Therapy of Immune Checkpoint Inhibitors as First-Line Treatment for Advanced Hepatocellular Carcinoma in Real-World Practice: A Systematic Literature Review and Meta-Analysis Journal article
Huimin Zou, Qing Lei, Xin Yan, Yunfeng Lai, Carolina Oi Lam Ung, Hao Hu. Clinical Outcomes Associated with Monotherapy and Combination Therapy of Immune Checkpoint Inhibitors as First-Line Treatment for Advanced Hepatocellular Carcinoma in Real-World Practice: A Systematic Literature Review and Meta-Analysis[J]. Cancers, 2022, 15(1), 260.
Authors:  Huimin Zou;  Qing Lei;  Xin Yan;  Yunfeng Lai;  Carolina Oi Lam Ung; et al.
Favorite | TC[WOS]:3 TC[Scopus]:3  IF:4.5/4.9 | Submit date:2023/02/08
Advanced Hepatocellular Carcinoma  Clinical Outcomes  First-line  Immune Checkpoint Inhibitors  Meta-analysis